• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·France·Consumer Defensive·MBWS.PA
Share

Marie Brizard Wine & Spirits SA Stocks

€ 2.78Last Updated 26.05.2026

Issuer Rating

3/7
Performance

Modest

Risk

Considerable

Recommendation

Sell

Market Cap

€ 364.70M

€ 2.78
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Very low or no dividends

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Marie Brizard Wine & Spirits SA engages in the producing, marketing, and selling wines and spirits in Western Europe, the Middle East, Africa, Central and Eastern Europe, the Americas, and Asia-Pacific. It primarily offers scotch whisky under the William Peel brand; vodka under the Sobieski and Krupnik brands; wine-based beverages under the Fruits and Wine brand name; liqueurs and syrups under the Marie Brizard brand; and cognac under the Cognac Gautier brand. The company was founded in 1755 and is based in Charenton-le-Pont, France. Marie Brizard Wine & Spirits SA operates as a subsidiary of Compagnie Financiere Europeenne De Prises De Participation SA.

Company Valuation

Overvalued
2/7

Considering past and projected metrics, the stock is 'expensive' compared to its peers. Specifically, the stock is 'expensive' on P/E, overvalued on EV/EBITDA, reasonably

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Slightly negative
3/7

The average target price of MBWS.PA is 2.7 and suggests 3% downside potential. Usually, this means a SELL recommendation among investment firms, or a recommendation to de

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

28.05.2026 01:26

All three major U.S. indexes hit records - the first time that has happened this year

27.05.2026 23:51

JPMorgan in search of a big deal: Dimon admits to a takeover worth up to $20 billion

27.05.2026 23:18

Has the energy shock reached Europe? Britons' energy costs set to soar to a two-year peak

27.05.2026 22:34

'Turning point': Lululemon settles dispute with founder. What about the stock?

27.05.2026 20:26

Michael Kors owner expects profit growth at the expense of youth. What about the stock?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026